acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor, not having achieved remission
acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor, not having achieved remission
acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor, not having achieved remission
acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor, not having achieved remission